替诺福韦联合索拉非尼治疗乙型肝炎相关中晚期原发性肝癌患者临床观察

doi:10.3969/j.issn.1672-5069.2021.04.037

Abstract

An Xiquan, Li Yan, Menggen Caicike. Clinical observation of tenofovir and sorafenib in the treatment of patients with hepatitis B associated advanced primary liver cancer[J]. Journal of Practical Hepatology, 2021, 24(4): 600-602.

References

[1] 罗杰,李向永,吴元凯,等.恩替卡韦初治及核苷酸类似物经治慢性乙型肝炎患者5年的疗效分析,中华实验和临床感染病杂志,2013,7(1):19-26.
[2] 戚勋,威越纯,张琴.恩替卡韦叠加聚乙二醇干扰素治疗慢性乙型肝炎患者48周疗效及安全性,中华传染病杂志,2013,31(3):181-182.
[3] 中华医学会肝病学分会、中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版).中华肝脏病杂志,2011,19:13-24.
[4] 王东盛,陆英,王成纲,等.恩替卡韦联合TACE治疗HBV DNA阳性原发性肝癌的临床研究,中国医药导刊,2011,22:867-868.
[5] 刘艺.拉米夫定联合阿德福韦酯治疗乙型肝炎肝硬化疗效观察.中国基层医药,2013,20:411-412.
[6] 张杰,施务务,葛少波,等.替诺福韦的合成工艺研究.Worldlatest medicine information(Electronic Version) .2015,15(50):130-131.
[7] Dickson I. Maternal tenofovir use does not improve prevention of perinatal HBV transmission. Nat Rev Gastroenterol Hepatol,2018,15(5):1242-1246.
[8] LinYY,Liu Y, Ding GF, et al. Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads. Sci Rep,2018,8(1):78-82.
[9] 顾梅,卢凯华,刘连科.索拉非尼的研究进展.国际肿瘤学杂志,2007,34(3):185-187.
[10] Kudo M, Galle PR, Llovet JM, et al. Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2. Liver Int, 2020,40(8):329-334.
[11] Chen ZB, Luo BY, Zou JJ, et al. Co-delivery of sorafenib and CRISPR/cas9 based on targeted core-shell hollow mesoporous organosilica nanoparticles for synergistic HCC therapy. ACS Appl Mater Interf,2020,12(51):1253-1258.
[12] 佘晶晶,郭东桃,雷琳.分子靶向药－索拉非尼对晚期肝癌的疗效.临床医药文献杂志2019,6(24):63-64.

[1]	Yu Lei, Sun Chao, Zhang Manxu. Regulation of intestinal floras and their metabolism functions by ganoderma lucidum plysaceharide in mice with HepG2 cell-induced implanted cancer [J]. Journal of Practical Hepatology, 2021, 24(4): 476-479.
[2]	Yang Yanqiu, Cheng Hao, Feng Min. Evaluation of significant liver fibrosis in patients with chronic hepatitis B by ultrasonic elastography and serological indexes [J]. Journal of Practical Hepatology, 2021, 24(4): 480-483.
[3]	Wu Hui, Song Bo, Lyu Chengxiu, et al. Change of serum endoplasmic reticulum stress parameters in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2021, 24(4): 484-487.
[4]	Sun Hairong, Feng Weiguang, Zhou Bingqing, et al. Liver stiffness measurement in patients with chronic hepatitis B viral infection and different alanine aminotransferase levels [J]. Journal of Practical Hepatology, 2021, 24(4): 488-491.
[5]	Zhang Jia, Jin Mingyuan, Du Yanyun, et al. Serum cytokine changes in patients with nonalcoholic fatty liver diseases and helicobacter pylori infection after clearance therapy [J]. Journal of Practical Hepatology, 2021, 24(4): 500-503.
[6]	Lu Xiaolong, Xie Chunbao. Implication of IL-6 gene polymorphism in short-term prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2021, 24(4): 516-519.
[7]	Liu Ying, He Xian, Tian Zhiying, et al. Clinical features and risk factors of acute kidney injury in patients with viral hepatitis B-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(4): 524-527.
[8]	Chen Wei, Wei Tao, Yang Lan, et al. Expression of NLRP3 inflammasome in cancerous tissues of patients with primary liver cancer [J]. Journal of Practical Hepatology, 2021, 24(4): 544-547.
[9]	Liu Yongchang, Zhao Diantang, Sun Qifeng, et al. Application of indocyanine green fluorescence navigationand three-dimensional visualization in laparoscopic precision surgery for patients with primary liver cancer [J]. Journal of Practical Hepatology, 2021, 24(4): 561-564.
[10]	Gao Jinlong, Wang Haifeng, Li Na, et al. Target delineation accuracy of tumors for radiotherapy based on MR-T2 image in patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2021, 24(4): 565-568.
[11]	Wang Xuemei, Zhang Yao, Yang Xueping, et al. Clinical application of ultrasound-guided percutaneous aspiration and percutaneous catheter drainage for treatment of liver abscess patients with or without AIDS [J]. Journal of Practical Hepatology, 2021, 24(4): 573-576.
[12]	Tang Wentao, Huang Hui, Cai Chanjuan. Long-term curative effects of transarterial embolization with pingyangmycin-lipiodol suspension in the treatment of patients with hepatic hemangioma [J]. Journal of Practical Hepatology, 2021, 24(4): 581-584.
[13]	Fu Qianguang, Li Qian, Feng Xiaoxue, et al. Clinical efficacy of laparoscopic common bile duct exploration and laparoscopic cholecystectomy combination in the treatment of patients with cholecystolithiasis and choledocholithiasis [J]. Journal of Practical Hepatology, 2021, 24(4): 589-592.
[14]	Wang Qunxian, Wang Yunchuan, Chen Youying. Effect of sevoflurane inhalation at different times during anesthesia in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2021, 24(4): 597-599.
[15]	Bi Zaihong, Hanbai Yila, Wang Bingyuan. Simvastatin: a newface for treatment of patients with chronic liver disease [J]. Journal of Practical Hepatology, 2021, 24(4): 603-606.

Clinical observation of tenofovir and sorafenib in the treatment of patients with hepatitis B associated advanced primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments